Stay updated with breaking news from Segmental Glomerulosclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Focal Segmental Glomerulosclerosis (FSGS) Therapeutics MarketThe global focal segmentmental glomerulosclerosis (FSGS) treatments market sales is expected to expand at a compound annual growth rate (CAGR) of 5% between 2023 and 2033, from US$ 3 billion in 2023 to US$ 4.89 billion by 2033. From 2018 to 2022, Focal Seg...
Your kidneys do a lot for you. But are you helping or hurting them? Click through the WebMD quiz to find out how you might be damaging your kidneys without even knowing it.
5 June, 2023 A busy start to Monday trading!Resources & Energy Group identifies large and shallow nickel deposit “with prospects for open cut development” and rockets 166%WA1 can do no wrong, hitting record highs in early trade on more thick high grade niobium drill resultsM3 Mining (gold), Solis (lithium) and Odessa (lithium, REE) up
Third-Quarter 2022 Results: -- Net Sales of $925.4 Million -- -- GAAP Net Income of $135.8 Million; Adjusted EBITDA of $335.3 Million, Which Includes $19.0 Million of Acquired IPR&D and Milestones
Second-Quarter 2022 Results:-- Net Sales of $876.4 Million; Orphan Segment Net Sales Increased 13% to $841.3 Million ---- GAAP Net Income of $61.0 Million; Adjusted EBITDA of $306.6 Million ---- TEPEZZA® (teprotumumab-trbw) Net Sales of $479.8 Million ---- KRYSTEXXA® (pegloticase injection) Net Sales of $167.8 Milli...